GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » EV-to-EBIT

Evolva Holding (XSWX:EVE) EV-to-EBIT : -0.21 (As of May. 01, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Evolva Holding EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Evolva Holding's Enterprise Value is CHF19.63 Mil. Evolva Holding's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-93.22 Mil. Therefore, Evolva Holding's EV-to-EBIT for today is -0.21.

The historical rank and industry rank for Evolva Holding's EV-to-EBIT or its related term are showing as below:

XSWX:EVE' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.32   Med: -4.07   Max: -0.21
Current: -0.22

During the past 13 years, the highest EV-to-EBIT of Evolva Holding was -0.21. The lowest was -19.32. And the median was -4.07.

XSWX:EVE's EV-to-EBIT is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 8.725 vs XSWX:EVE: -0.22

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Evolva Holding's Enterprise Value for the quarter that ended in Jun. 2023 was CHF33.60 Mil. Evolva Holding's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-93.22 Mil. Evolva Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -277.46%.


Evolva Holding EV-to-EBIT Historical Data

The historical data trend for Evolva Holding's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding EV-to-EBIT Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.88 -6.47 -5.29 -3.30 -2.38

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.30 - -2.38 -

Competitive Comparison of Evolva Holding's EV-to-EBIT

For the Biotechnology subindustry, Evolva Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Evolva Holding's EV-to-EBIT falls into.



Evolva Holding EV-to-EBIT Calculation

Evolva Holding's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19.626/-93.222
=-0.21

Evolva Holding's current Enterprise Value is CHF19.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-93.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding  (XSWX:EVE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Evolva Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-93.222/33.5989232
=-277.46 %

Evolva Holding's Enterprise Value for the quarter that ended in Jun. 2023 was CHF33.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-93.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Evolva Holding's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding (XSWX:EVE) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.